Background: Anti-phospholipase A2 receptor (PLA2R) antibodies are specific to the
diagnosis of primary membranous nephropathy (pMN). The prevalence of positive …

Background Phospholipase A2 receptor (PLA2R) has been identified as a major
autoantigen in primary membranous nephropathy (MN). We evaluated the association …

Introduction Primary membranous nephropathy (PMN) is associated with the anti-
phospholipase A2 receptor (anti-PLA2R) antibody in 70% of cases. Some anti-PLA2R …

Membranous nephropathy (MN) is one of the most common causes of nephrotic syndrome
in native kidney biopsies from adults. In 2009, antibodies to the M-type receptor of …

Background: Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is useful in diagnosing
idiopathic membranous nephropathy (IMN). We investigated the clinical relevance of PLA2R …

Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adults,
with an uncertain clinical outcome. The characterization of the phospholipase A 2 receptor …

Background: The diagnostic role of circulating anti-phospholipase A2 receptor antibodies
(anti-PLA2R Abs) is now well recognized in idiopathic membranous nephropathy (iMN) …

Background: M-type phospholipase A 2 receptor (PLA 2 R) has been identified as the major
target antigen in idiopathic membranous nephropathy (IMN). However, the role of …

Autoantibodies to M-type phospholipase A2 receptor (PLA2R) are specific markers of
idiopathic membranous nephropathy (IMN). They can differentiate IMN from other …

Results 77.8% of iMN patients in our cohort had antibodies reactive with human PLA 2 R.
The antibody levels in these patients correlated strongly with both clinical status and …